ORPHA:228302
Carnitine palmitoyl transferase II deficiency, myopathic form
Also known as: Carnitine palmitoyl transferase II deficiency, adult-onset form · Carnitine palmitoyl transferase deficiency type 2, adult-onset form · Carnitine palmitoyl transferase deficiency type 2, myopathic form · CPT2, adult-onset form · CPT2, myopathic form · CPTII, adult-onset form · CPTII, myopathic form
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
4
18.9th percentile
Trials
0
Interventional, condition-specific
Researchers
56
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited disorder that affects oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0009704
- MeSH:C563461
- OMIM:255110
- UMLS:C1833508
Additional Mondo synonyms (2)
CPT II deficiency, myopathic, stress-induced · carnitine palmitoyl transferase II deficiency, myopathic form
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
4 matched papers (4 in last 10 years) Source
- Phenotype characterisedPresent
28 HPO annotations (e.g. Red-brown urine; Muscle weakness; Elevated circulating long chain fatty acid concentration) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
28
Associated phenotypes · MONDO:0009704
- Red-brown urine
- Muscle weakness
- Elevated circulating long chain fatty acid concentration
- Tubulointerstitial nephritis
- Rhabdomyolysis
Showing 5 of 28 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-27
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
4
4 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
4 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
4 in the last 10 years · high confidence · 18.9th percentile (publications denominator)
Phrase hits: 4 · MeSH hits: 0
Who's working on it?
56
Distinct author names in 4 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Alberto JM1 paper · 2024
Inserm UMRS 1256 NGERE - Nutrition, Genetics, and Environmental Risk Exposure, University of Lorraine, Nancy, F-54000, France.
Papers in Europe PMC - 02Alfadhel M1 paper · 2019
Division of Genetics, Department of Pediatrics, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (MNGHA), Riyadh 11426, Saudi Arabia. dralfadhelm@gmail.com.
Papers in Europe PMC - 03Almannai M1 paper · 2019
Section of Medical Genetics, Children's Hospital, King Fahad Medical City, Riyadh 11525, Saudi Arabia. malmannai@kfmc.med.sa.
Papers in Europe PMC - 04Attarian S1 paper · 2022
Service de Neurologie, FILNEMUS, Hôpital La Timone, CHU de Marseille, 13385 Marseille, France.
Papers in Europe PMC - 05Bartoli M1 paper · 2022
INSERM, Marseille Medical Genetics, U1251, Aix-Marseille Université, 13385 Marseille, France.
Papers in Europe PMC - 06Baspinar O1 paper · 2024
Inserm UMRS 1256 NGERE - Nutrition, Genetics, and Environmental Risk Exposure, University of Lorraine, Nancy, F-54000, France.
Papers in Europe PMC - 07Biancalana V1 paper · 2022
Laboratoire de Diagnostic Génétique CHU de Strasbourg, 67091 Strasbourg, France.
Papers in Europe PMC - 08Blasi F1 paper · 2023
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Papers in Europe PMC - 09Bonne G1 paper · 2022
Centre de Recherche en Myologie, Institut de myologie, Sorbonne Université, Inserm, 75013 Paris, France.
Papers in Europe PMC - 10Bourdain CA1 paper · 2022
Service Biochimie et Biologie Moléculaire Grand Est-UM Maladies Héréditaires du Métabolisme, HCL, 69002 Lyon, France.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 9 September 2026 · last trial check 9 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-27
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Carnitine palmitoyl transferase II deficiency, myopathic form — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Carnitine palmitoyl transferase II deficiency, myopathic form" OR "Carnitine palmitoyl transferase II deficiency, adult-onset form" OR "Carnitine palmitoyl transferase deficiency type 2, adult-onset form" OR "Carnitine palmitoyl transferase deficiency type 2, myopathic form" OR "CPT2, adult-onset form" OR "CPT2, myopathic form" OR "CPTII, adult-onset form" OR "CPTII, myopathic form" OR "CPT II deficiency, myopathic, stress-induced"
MeSH descriptor terms unioned into the query: Carnitine Palmitoyltransferase II Deficiency, Late-Onset
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Carnitine palmitoyl transferase II deficiency, myopathic form" OR "Carnitine palmitoyl transferase II deficiency, adult-onset form" OR "Carnitine palmitoyl transferase deficiency type 2, adult-onset form" OR "Carnitine palmitoyl transferase deficiency type 2, myopathic form" OR "CPT2, adult-onset form" OR "CPT2, myopathic form" OR "CPTII, adult-onset form" OR "CPTII, myopathic form" OR "CPT II deficiency, myopathic, stress-induced" OR "Carnitine Palmitoyltransferase II Deficiency, Late-Onset"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T02:12:16.143Z